Literature DB >> 1349754

Benzodiazepine-induced sedation and cortisol suppression. A placebo-controlled comparison of oxazepam and nitrazepam in healthy male volunteers.

P Christensen1, A Lolk, L F Gram, P Kragh-Sørensen.   

Abstract

The sedative and cortisol suppressing properties of oxazepam (45 and 60 mg) and nitrazepam (10 and 15 mg) were examined in eight healthy male subjects. The most clear differences between oxazepam and nitrazepam were those seen with respect to the time course and until maximal effect (Tmax) of the different measurements. Nitrazepam showed maximal sedation after 1 h, maximal benzodiazepine level (RRA), and reaction time prolongation after 2 h, and maximal cortisol suppression after 3 h. Oxazepam showed maximal sedation after 2 h, maximal benzodiazepine levels, reaction time prolongation and cortisol suppression after 3 h. After administration of oxazepam (both doses) a transient return to baseline levels of cortisol was demonstrated. Whereas the degree of sedation correlated significantly within drug groups with the concurrent benzodiazepine levels, the Tmax of sedation was recorded 1 h earlier than the peak blood concentration (RRA) for both nitrazepam and oxazepam. The time course for cortisol suppression for the two compounds differed clearly from the other measurements and was not related to the peak blood concentration.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1349754     DOI: 10.1007/bf02244823

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  10 in total

1.  Factors modifying the effect of diazepam on plasma corticosterone levels in rats.

Authors:  L A Pohorecky; S Cotler; J J Carbone; P Roberts
Journal:  Life Sci       Date:  1988       Impact factor: 5.037

2.  Some studies of the protein-binding of steroids and their application to the routine micro and ultramicro measurement of various steroids in body fluids by competitive protein-binding radioassay.

Authors:  B E Murphy
Journal:  J Clin Endocrinol Metab       Date:  1967-07       Impact factor: 5.958

3.  The cortisol suppressing effect of dexamethasone and oxazepam in depressed patients; significance of spontaneous levels and interindividual distribution.

Authors:  P Christensen; L F Gram; A Lolk; P Kragh-Sørensen
Journal:  J Affect Disord       Date:  1987 Nov-Dec       Impact factor: 4.839

4.  Suppression of plasma cortisol after oral administration of oxazepam in man.

Authors:  L F Gram; L Christensen; C B Kristensen; P Kragh-Sorensen
Journal:  Br J Clin Pharmacol       Date:  1984-02       Impact factor: 4.335

Review 5.  GABAergic control of anterior pituitary hormone secretion.

Authors:  G Racagni; J A Apud; D Cocchi; V Locatelli; E E Muller
Journal:  Life Sci       Date:  1982-08-30       Impact factor: 5.037

6.  Radioreceptor assay for benzodiazepines in biological fluids using a new dry and stable receptor preparation.

Authors:  J Lund
Journal:  Scand J Clin Lab Invest       Date:  1981-05       Impact factor: 1.713

Review 7.  The dexamethasone suppression test: an overview of its current status in psychiatry. The APA Task Force on Laboratory Tests in Psychiatry.

Authors: 
Journal:  Am J Psychiatry       Date:  1987-10       Impact factor: 18.112

8.  Spontaneous afternoon plasma cortisol in depression.

Authors:  P Christensen; L F Gram; P Kragh-Søensen; L Christensen; C B Kristensen; O L Pedersen; H Y Thomsen
Journal:  J Affect Disord       Date:  1985 May-Jun       Impact factor: 4.839

9.  Afternoon plasma cortisol in relation to depression. A replication study.

Authors:  P Christensen; A Lolk; O L Pedersen; S Nielsen; P Kragh-Sørensen; L F Gram
Journal:  Acta Psychiatr Scand       Date:  1988-12       Impact factor: 6.392

10.  Afternoon cortisol levels before (spontaneous) and after suppression with dexamethasone or oxazepam in depressed patients.

Authors:  P Christensen; L F Gram; P Kragh-Sørensen; S Nielsen
Journal:  J Affect Disord       Date:  1986 May-Jun       Impact factor: 4.839

  10 in total
  6 in total

Review 1.  Biomarkers for the effects of benzodiazepines in healthy volunteers.

Authors:  S J de Visser; J P van der Post; P P de Waal; F Cornet; A F Cohen; J M A van Gerven
Journal:  Br J Clin Pharmacol       Date:  2003-01       Impact factor: 4.335

2.  Bretazenil modulates sleep EEG and nocturnal hormone secretion in normal men.

Authors:  J Guldner; L Trachsel; C Kratschmayr; B Rothe; F Holsboer; A Steiger
Journal:  Psychopharmacology (Berl)       Date:  1995-11       Impact factor: 4.530

3.  Inhibitory effect of diazepam on the activity of the hypothalamic-pituitary-adrenal axis in female rats.

Authors:  N Pivac; D Pericić
Journal:  J Neural Transm Gen Sect       Date:  1993

4.  Effects of oxazepam on eye movements and performance in vigilance tasks with static and dynamic stimuli.

Authors:  T H van Leeuwen; M N Verbaten; H S Koelega; G Camfferman; J van der Gugten; J L Slangen
Journal:  Psychopharmacology (Berl)       Date:  1994-02       Impact factor: 4.530

5.  Effects of flumazenil on recovery sleep and hormonal secretion after sleep deprivation in male controls.

Authors:  E Seifritz; U Hemmeter; L Trachsel; C J Lauer; M Hatzinger; H M Emrich; F Holsboer; E Holsboer-Trachsler
Journal:  Psychopharmacology (Berl)       Date:  1995-08       Impact factor: 4.530

6.  Flumazenil exerts intrinsic activity on sleep EEG and nocturnal hormone secretion in normal controls.

Authors:  A Steiger; J Guldner; C J Lauer; C Meschenmoser; T Pollmächer; F Holsboer
Journal:  Psychopharmacology (Berl)       Date:  1994-01       Impact factor: 4.530

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.